Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Skye Bioscience ( (SKYE) ) just unveiled an announcement.
On May 13, 2026, Skye Bioscience disclosed that Nasdaq notified the company it was out of compliance with the Nasdaq Global Market’s minimum $10 million stockholders’ equity requirement, after reporting $9,011,804 in equity as of March 31, 2026. The notice does not immediately affect trading of Skye’s common stock, which continues under the SKYE ticker, but it puts the company under heightened scrutiny and raises potential risk to its listing if it cannot restore equity levels.
Skye has until June 29, 2026, to submit a plan to regain compliance and could receive up to 180 days from the notice date, or until November 9, 2026, to meet the equity threshold if Nasdaq accepts the plan. If Nasdaq rejects the plan, Skye can appeal while its stock remains listed during the process, and the company is currently evaluating options to bolster stockholders’ equity, a process that may affect capital structure and existing shareholders’ interests.
The most recent analyst rating on (SKYE) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Skye Bioscience stock, see the SKYE Stock Forecast page.
Spark’s Take on SKYE Stock
According to Spark, TipRanks’ AI Analyst, SKYE is a Neutral.
The score is primarily weighed down by very weak financial performance (no revenue, large losses, and significant cash burn with shrinking equity) and a negative listing-compliance event. Technical indicators are only neutral-to-weak and do not offset the fundamental and event-driven risks, while valuation metrics provide limited support due to negative earnings and no dividend yield.
To see Spark’s full report on SKYE stock, click here.
More about Skye Bioscience
Skye Bioscience, Inc. is a publicly traded biopharmaceutical company whose common stock is listed on the Nasdaq Global Market under the symbol SKYE. The company’s capital structure and stockholders’ equity position are central to maintaining its listing status on this major U.S. exchange, which is important for investor access and liquidity.
Average Trading Volume: 505,983
Technical Sentiment Signal: Sell
Current Market Cap: $30.62M
Learn more about SKYE stock on TipRanks’ Stock Analysis page.